{"id":"W4316086120","doi":"10.14309/01.ajg.0000859848.43617.3c","title":"S802 Persistence Among Patients With Crohn’s Disease Previously Treated With an Anti-tumor Necrosis Factor Inhibitor and Switching or Cycling to Another Biologic Agent","year":2022,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Adalimumab; Medicine; Vedolizumab; Infliximab; Ustekinumab; Internal medicine; Persistence (discontinuity); Discontinuation; Tumor necrosis factor alpha; Crohn's disease; Gastroenterology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007480601,0.0001734065,0.0003457626,0.0007028282,0.0003599392,0.0007959513,0.0002472541,0.0004284773,0.003647394],"category_scores_gemma":[0.002184287,0.0001431819,0.0005439527,0.001048419,0.0002292233,0.0006138211,0.0004657344,0.0004529758,0.0004593572],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003725411,"about_ca_system_score_gemma":0.0004021288,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002095853,"about_ca_topic_score_gemma":0.001826577,"domain_scores_codex":[0.9994173,0.0001157223,0.0001270234,0.0001434137,0.0001012516,0.00009530586],"domain_scores_gemma":[0.9977716,0.0003805256,0.001277235,0.00008924589,0.0001683185,0.0003130733],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006477024,0.00008173253,0.9969525,0.00003002915,0.00007480512,0.00005511687,0.00006573359,0.00003508213,0.00008432757,0.00001775058,0.0001759018,0.001779243],"study_design_scores_gemma":[0.000103798,0.00104168,0.9965737,0.00004577316,0.00009845498,0.0005478014,0.0003147853,0.0003499258,0.00007296853,0.00006740208,0.0007731901,0.00001053602],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988397,0.0001974587,0.00002471094,0.00003684118,0.000005004763,0.000009283737,0.0005640096,0.000001759052,0.0003213135],"genre_scores_gemma":[0.9986545,0.00009352885,0.00003947876,0.00004326308,0.00002046134,0.00001587871,0.0009803727,0.000001501437,0.0001509763],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003647394,"threshold_uncertainty_score":0.01220173,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008455118583356461,"score_gpt":0.2140554175893682,"score_spread":0.2056002990060118,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}